Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/22/21 16:26 | 1/22/21 | PRVL | Health | Drug | Pharmaceutical Preparations | Tyto Acquisition Corp | IN | T | P | 771,408 | 22.50 | 0 | 34,285 | 0 | D | ||||||||||||||||
12/31/20 16:54 | 12/30/20 | PRVL | Health | BioPrd | Biological Products, (No Diag | Abeliovich Asa | NY | DO | P,CEO | M.d | 1,238 | 9.84 | 0 | 126 | 6 | 2,386 | D | ||||||||||||||
3/11/20 16:47 | 12/24/19 | PRVL | Health | BioPrd | Biological Products, (No Diag | Minkow Emily | NY | O | Chief Bu | M.d | 2 | 0.1800 | 0 | 13 | New | 13 | D | ||||||||||||||
6/26/19 16:56 | 6/24/19 | PRVL | Health | BioPrd | Biological Products, (No Diag | Thompson Peter A. | NY | DT | P.d | 15,000 | 17.00 | 0 | 882 | 7 | 13,822 | I | |||||||||||||||
6/26/19 16:55 | 6/24/19 | PRVL | Health | BioPrd | Biological Products, (No Diag | Gordon Carl L | NY | DT | P.d | 15,000 | 17.00 | 0 | 882 | 7 | 13,822 | I | |||||||||||||||
6/26/19 16:54 | 6/24/19 | PRVL | Health | BioPrd | Biological Products, (No Diag | Orbimed Advisors LLC | NY | DT | P.d | 15,000 | 17.00 | 0 | 882 | 7 | 13,822 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |